Astrazeneca Pharma India standalone net profit declines 13.43% in the June 2020 quarter
Sales decline 5.37% to Rs 193.58 crore
Net profit of Astrazeneca Pharma India declined 13.43% to Rs 18.63 crore in the quarter ended June 2020 as against Rs 21.52 crore during the previous quarter ended June 2019. Sales declined 5.37% to Rs 193.58 crore in the quarter ended June 2020 as against Rs 204.56 crore during the previous quarter ended June 2019. ParticularsQuarter EndedJun. 2020Jun. 2019% Var.Sales193.58204.56 -5 OPM %14.7517.39 -PBDT30.9438.27 -19 PBT26.3833.64 -22 NP18.6321.52 -13Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 10 2020 | 2:40 PM IST